Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase.
Chan, P.F., Germe, T., Bax, B.D., Huang, J., Thalji, R.K., Bacque, E., Checchia, A., Chen, D., Cui, H., Ding, X., Ingraham, K., McCloskey, L., Raha, K., Srikannathasan, V., Maxwell, A., Stavenger, R.A.(2017) Proc Natl Acad Sci U S A 114: E4492-E4500
- PubMed: 28507124 
- DOI: https://doi.org/10.1073/pnas.1700721114
- Primary Citation of Related Structures:  
5NPK, 5NPP - PubMed Abstract: 
A paucity of novel acting antibacterials is in development to treat the rising threat of antimicrobial resistance, particularly in Gram-negative hospital pathogens, which has led to renewed efforts in antibiotic drug discovery. Fluoroquinolones are broad-spectrum antibacterials that target DNA gyrase by stabilizing DNA-cleavage complexes, but their clinical utility has been compromised by resistance ...